B. Metzler seel. Sohn & Co. AG Invests $20.36 Million in Danaher Corporation $DHR

B. Metzler seel. Sohn & Co. AG acquired a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 28,281 shares of the conglomerate's stock, valued at approximately $20,363,000.

• The Often-Missed Corner of Healthcare That Wall Street Is Loving

Other institutional investors also recently added to or reduced their stakes in the company. Sivia Capital Partners LLC increased its holdings in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock valued at $397,000 after buying an additional 119 shares during the last quarter. First Trust Advisors LP grew its position in shares of Danaher by 34.5% during the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate's stock valued at $10,947,000 after buying an additional 14,217 shares during the last quarter. Main Street Financial Solutions LLC raised its stake in Danaher by 40.2% during the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate's stock worth $610,000 after acquiring an additional 886 shares during the period. Ieq Capital LLC lifted its holdings in Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate's stock worth $14,957,000 after acquiring an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC lifted its holdings in Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock worth $273,000 after acquiring an additional 325 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Trading Up 1.6%

NYSE:DHR opened at $219.42 on Friday. The company has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.69 and a beta of 0.78. The stock's 50 day moving average price is $195.80 and its 200 day moving average price is $192.61. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80.

• An AI Play Hiding in Plain Sight: A Look at Johnson Controls

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher's quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.77 EPS. On average, research analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on DHR. Wolfe Research lowered Danaher from an "outperform" rating to a "peer perform" rating in a report on Monday, June 1st. Guggenheim cut their target price on Danaher from $235.00 to $200.00 and set a "buy" rating on the stock in a research note on Wednesday, July 22nd. Piper Sandler started coverage on Danaher in a research note on Thursday, June 11th. They issued a "neutral" rating and a $200.00 price target for the company. Wells Fargo & Company lowered their price target on Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 22nd. Finally, Argus cut their price objective on shares of Danaher from $265.00 to $230.00 and set a "buy" rating on the stock in a research note on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, Danaher currently has an average rating of "Moderate Buy" and a consensus price target of $228.91.

• 3 Stocks Offering Strong Value and Stability

Check Out Our Latest Stock Analysis on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

• Five stocks we like better than Danaher
• Blueprint for a Boom: SEC Clears the Crypto Runway
• Ross Stores Just Flipped the Off-Price Retail Story After TJX's Marmaxx Miss
• Advance Auto Parts Plunged, But Its Turnaround Is Still Working
• Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here